The global protein engineering market is projected to reach USD 14.7 billion in 2026, growing at a CAGR of 13.5% from 2023 to 2031
Protein Engineering Market: Breakup by Region, 2022 & 2031
Source: Primary Research and Secondary Research Analysis
Protein engineering is the process of modifying proteins by altering their structure, catalytic ability, or expression in an organism. It is used to create therapeutic proteins and enzymes that are used to treat diseases, disorders, and infections. It is also used to develop enzymes for industrial and agricultural processes.
The growth of the protein engineering market is attributed to the increasing prevalence of genetic diseases, rising demand for biopharmaceuticals, and increasing investments in research and development activities. Additionally, the increasing demand for plant-based proteins, rising demand for monoclonal antibodies, and the introduction of new technologies are further driving the growth of the market. However, the high cost of research and development activities and ethical concerns associated with the use of genetically modified organisms are the major factors restraining the growth of the market.
The global protein engineering market is segmented based on application, end-user, and region. By application, the market is divided into drug discovery and development, diagnostic testing, and research and development. The drug discovery and development segment is expected to account for the largest share of the market during the forecast period. This is attributed to the rising prevalence of genetic diseases and increasing investments in research and development activities. By end-user, the market is divided into biopharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations (CROs). The biopharmaceutical and biotechnology companies segment is anticipated to grow at a higher CAGR during the forecast period. This can be attributed to the rising demand for biopharmaceuticals and the increasing research and development activities carried out by biopharmaceutical and biotechnology companies.
Geographically, the protein engineering market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to account for the largest share of the market during the forecast period. This is attributed to the increasing prevalence of genetic diseases, rising investments in research and development activities, and the presence of well-established players in the region.
Source: Primary Research and Secondary Research Analysis
Furthermore, the Growing demand for the protein engineering instruments for the invention of cutting-edge treatments has also boosted the growth. Government efforts focused on protein engineering improvement capabilities are predicted to offer lucrative opportunity and potential for the market. Increase in research activities and programs, the rising funding, and R&D spending is also a driving factor. For instance, in Dec 2021, Nabla Bio announced the closure of a USD 11 million seed fundraising round. With the help of this financing, a platform for AI-first design platform will be developed for enabling the development of next-generation antibody therapeutics. Moreover, growing number of private and public investments in synthetic biology, and ongoing developments in protein engineering p, is expected to witness substantial growth in the near future.
Market Breakup By Product
Instruments
Reagents
Software & Services
Market Breakup By Technology
Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others
Market Breakup By Protein Type
Insulin
Monoclonal Antibodies
Vaccines
Colony Stimulating Factors
Coagulation Factors
Others
Market Breakup By End-use
Academic Research Institutes
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
Regional Analysis
The report has been prepared after analysing and reviewing numerous factors that denotes the regional development such as economic, environmental, social, technological, and political inputs of the country. The researchers have closely analysed the data of revenue, production, and manufacturers of each county. These analyses will help the to identify the important areas as potential worth of investment in the upcoming years.
Market Breakup By Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The reader can will get an updated information on their revenue of manufacturers, product portfolio, recent development and expansion plans during the forecast period
Major players operating in the Protein Engineering market are:
Agilent Technologies
Bruker Cor.
Thermo Fisher Scientific, Inc.
PerkinElmer, Inc.
Waters Corp.
Bio-Rad Laboratories
Merck KGaA
Danaher Corp.
Genscript Biotech Corp.
Amgen, Inc.
Others
Global Protein Engineering Market Research Report, 2020-2031.
Table of Contents
On Request
Our reports with in-depth insights will equip you to succeed in your business plans.
Get instant access to the information you need to make the right decision.
Explore where opportunities lie for you and mitigate the risks.
We are one of the most trusted brands setting benchmarks of excellence.